Home Ingredients Potassium Bicarbonate
Bone Health

Potassium Bicarbonate

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Potassium bicarbonate (KHCO3) is an alkalizing potassium salt studied mainly for bone and acid-base health rather than simple potassium repletion. Providing about 39% elemental potassium, it delivers potassium together with bicarbonate, a base that neutralizes the modest acid load generated by typical Western diets and that tends to increase with age. In older adults, supplemental potassium bicarbonate has been shown to lower urinary calcium loss and reduce a marker of bone breakdown. However, these are surrogate biochemical endpoints. A meta-analysis of alkaline potassium salts found that the reductions in urinary calcium and bone-resorption markers were not accompanied by any change in bone mineral density, and no trial has measured fractures. Controlled comparisons indicate the bicarbonate, not the potassium, is responsible for the marker changes. The research doses are many times a normal supplement serving and carry a real risk of high blood potassium.

Studied Dose Bone-turnover trials in adults aged 50 and older used either a fixed 67.5 mmol per day for 3 months or weight-based doses of 1 to 1.5 mmol/kg per day, which worked out to median doses of 81 and 122 mmol per day; a separate 24-week trial in adults aged 65 and older used 81 mmol per day. That is roughly 6.8 to 12 g of potassium bicarbonate daily, delivering about 2,600 to 4,800 mg of elemental potassium, or 26 to 48 times the 99 mg per serving that US supplement makers voluntarily observe. Participants were screened for normal kidney function and had blood potassium checked repeatedly during treatment.
Active Compound Potassium bicarbonate (KHCO3), an alkaline potassium salt providing roughly 39% elemental potassium plus bicarbonate as an alkalizing buffer.

Benefits

Supports Bone Mineral Conservation

By providing alkali that buffers dietary acid load, potassium bicarbonate has been shown to reduce urinary calcium excretion in older adults, which may help the body conserve calcium that would otherwise be lost in the urine.

Supported by Trial 1, Trial 2

May Lower Bone Breakdown Markers

Supplementation has been associated with reductions in a urinary marker of bone resorption, though a bone-formation marker fell alongside it, pooled trials of alkaline potassium salts show no accompanying change in bone mineral density, and no effect on fracture risk has been demonstrated.

Supported by Trial 1, Trial 2

Counters Dietary Acid Load

Typical modern diets generate a low-grade metabolic acid load that rises with age; the bicarbonate component helps neutralize this load and supports normal acid-base balance, the proposed basis for its skeletal effects.

Supported by Trial 1, Trial 2

Provides Alkalizing Potassium

Unlike neutral potassium salts, potassium bicarbonate supplies potassium alongside base, helping maintain potassium status while also contributing to the body's buffering capacity.

Supported by Trial 2, Trial 1

Supports Healthy Aging Of Bone

Because age-related acidosis is thought to contribute to gradual calcium loss, alkalizing supplementation is of interest for supporting bone health during aging, recognizing the evidence rests on biochemical rather than fracture outcomes.

Supported by Trial 2, Trial 1

Mechanism of action

1

Acid-Base Buffering

The bicarbonate anion neutralizes hydrogen ions from dietary acid precursors, raising systemic buffering capacity and reducing the chronic low-grade metabolic acidosis associated with high-protein, low-vegetable diets and aging.

2

Reduced Calcium Wasting

Lowering the acid load decreases the need to mobilize alkaline bone salts and reduces renal calcium excretion, helping retain calcium in the body rather than losing it through the urine.

3

Bone Turnover Modulation

Acid loading stimulates osteoclastic bone resorption while suppressing osteoblastic activity; supplying base is proposed to shift this balance, reflected in reduced bone-resorption markers in supplementation trials.

4

Bicarbonate Is The Active Component

Controlled comparisons indicate the alkalizing bicarbonate, rather than the potassium ion itself, drives the reductions in calcium excretion and bone resorption, distinguishing this salt from neutral potassium forms.

Clinical trials

1
Potassium bicarbonate dose-finding trial on bone turnover

Double-blind, placebo-controlled randomized dose-finding trial of placebo, 1 mmol/kg, or 1.5 mmol/kg KHCO3 daily for 3 months (median doses 81 and 122 mmol/day); all participants also received 600 mg calcium and 500 IU vitamin D. Dawson-Hughes B et al, J Bone Miner Res 2015;30(11):2103-11 (PMID 25990255, NCT01475214)

244 healthy men and women aged 50 and older, screened for an eGFR of at least 50 mL/min and serum potassium of 5.3 mEq/L or below; 233 completed

The lower dose reduced the bone-resorption marker urinary NTX by 18.7% and the bone-formation marker serum P1NP by 10.7%, and both doses reduced urinary calcium versus placebo. The higher dose did not significantly reduce either bone marker and caused more episodes of hyperkalemia, and five participants stopped the supplement because their kidney filtration rate declined. There was no effect on urinary nitrogen excretion, IGF-1, grip strength, stair-climb time or the Short Physical Performance Battery. Bone mineral density and fractures were not measured.

2
Bicarbonate versus potassium on calcium and bone resorption

Double-blind randomized trial of placebo, potassium bicarbonate, sodium bicarbonate or potassium chloride, each at 67.5 mmol/day for 3 months, designed to separate the bicarbonate anion from the potassium cation; all participants received 600 mg calcium and 525 IU vitamin D. Dawson-Hughes B et al, J Clin Endocrinol Metab 2009;94(1):96-102 (PMID 18940881)

171 men and women aged 50 and older were randomized; 162 were included in the analyses

Participants taking either bicarbonate salt had significant reductions in 24-hour urinary N-telopeptide and calcium compared with those taking no bicarbonate, while potassium supplementation on its own changed neither. Outcomes were urinary markers measured at entry and at 3 months; bone density and fractures were not assessed.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal upset, gas, or bloating can occur, particularly at higher daily doses.
Hyperkalemia, or high blood potassium, is the main hazard; it can disturb heart rhythm, and it occurred at the higher research dose even among participants pre-screened for normal kidney function and normal baseline potassium.
The alkalizing effect can shift systemic acid-base balance if taken in large amounts.
People with kidney impairment are at increased risk of potassium accumulation, and in one trial five participants stopped the supplement because their kidney filtration rate declined during treatment.
Fracture-prevention benefit is unproven, so it should not replace established bone-health measures.

Important Drug interactions

ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia.
Angiotensin receptor blockers (ARBs) likewise elevate potassium and warrant caution.
Potassium-sparing diuretics such as spironolactone, amiloride and triamterene can cause dangerous hyperkalemia with added potassium salts, as can NSAIDs and trimethoprim, which also reduce potassium excretion.
People with chronic kidney disease should use potassium bicarbonate only under medical supervision due to hyperkalemia risk.

More Bone Health Ingredients

Bone Health
Calcium
Calcium is the most abundant mineral in the body — about 99% stored in bones and teeth, wi…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Bone Health
Ferrous Sulfate
Ferrous sulfate is the most common, cheapest, and longest-established oral iron form — rec…
Bone Health
Vitamin K
Vitamin K is a fat-soluble vitamin essential for blood clotting and for directing calcium…

Frequently asked questions about Potassium Bicarbonate

What is potassium bicarbonate used for?

Potassium bicarbonate provides potassium in an alkalizing (base-forming) form. It has been studied mainly for buffering dietary acid load, where it lowers urinary calcium loss and a marker of bone breakdown. Trials that looked for effects on muscle power, physical performance and muscle mass found none, and in a crossover trial in adults with mildly raised blood pressure, potassium bicarbonate did not significantly lower blood pressure.

Why choose potassium bicarbonate?

It is chosen when the goal is to neutralize acid, since the bicarbonate counters the acid produced by a typical Western diet. Research in older adults shows it lowers urinary calcium loss and bone-resorption markers, but a meta-analysis of alkaline potassium salts found no effect on bone mineral density, and a 24-week trial at the same dose found no effect on muscle power, physical performance or muscle mass.

How much potassium bicarbonate should I take?

Most US supplements hold to 99 mg of potassium per serving, but this is a voluntary industry practice rather than a legal limit on supplements: the FDA ruling behind the figure applies to oral drug products containing potassium chloride, which were linked to small-bowel lesions above that amount. The research doses of potassium bicarbonate are 26 to 48 times that serving size, were given only to people screened for normal kidney function, and were accompanied by repeated blood potassium tests. They are not doses to reproduce on your own. Prioritize potassium-rich foods and speak to your doctor before taking any potassium supplement.

Is potassium bicarbonate safe?

In small amounts it is generally well tolerated. The main hazard is hyperkalemia, or high blood potassium, which can disturb heart rhythm. Risk is highest with reduced kidney function, in older adults, and alongside ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs or trimethoprim. Even in a trial that excluded people with impaired kidney function, some participants had to stop the higher dose because of confirmed hyperkalemia or a fall in kidney filtration. As a bicarbonate it can also cause burping or mild stomach upset.

What is Potassium Bicarbonate?

Potassium bicarbonate (KHCO3) is an alkalizing potassium salt studied mainly for bone and acid-base health rather than simple potassium repletion. Providing about 39% elemental potassium, it delivers potassium together with bicarbonate, a base that neutralizes the modest acid load generated by typical Western diets and…

What is the recommended dosage of Potassium Bicarbonate?

The clinically studied dose is Bone-turnover trials in adults aged 50 and older used either a fixed 67.5 mmol per day for 3 months or weight-based doses of 1 to 1. Always follow the product label and check with a healthcare provider for personal advice.

Is Potassium Bicarbonate safe, and does it have side effects?

For most healthy adults, Potassium Bicarbonate is well tolerated at studied doses. Reported effects can include: Gastrointestinal upset, gas, or bloating can occur, particularly at higher daily doses. Hyperkalemia, or high blood potassium, is the main hazard; it can disturb heart rhythm, and it occurred at the higher research dose even among participants pre-screened for normal kidney funct… It may also interact with some medications. Potassium Bicarbonate is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Potassium Bicarbonate interact with any medications?

Possible interactions include: ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia. Angiotensin receptor blockers (ARBs) likewise elevate potassium and warrant caution. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Potassium Bicarbonate?

NutraSmarts rates the evidence for Potassium Bicarbonate as Limited (2 out of 5). It is backed by 2 clinical trials and 7 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(7 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Dawson-Hughes B, Harris SS, Palermo NJ, Gilhooly CH, Shea MK, Fielding RA, Ceglia L Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial Journal of Bone and Mineral Research. 2015;J Bone Miner Res. 2015 Nov;30(11):2103-11.PubMedUsed to support: Randomized double-blind dose-finding trial in 244 adults aged 50 and older, screened for an eGFR of at least 50 mL/min/1.73 m2. Potassium bicarbonate at 1 mmol/kg/day (median 81 mmol/day) for 3 months lowered urinary NTX by 18.7% and serum P1NP by 10.7%, and both dose arms lowered urinary calcium versus placebo. The higher 1.5 mmol/kg/day dose did not significantly reduce either bone marker and caused more episodes of hyperkalemia. There was no effect on urinary nitrogen excretion, IGF-1, grip strength or physical function measures. Bone mineral density and fractures were not measured.
  2. Dawson-Hughes B, Harris SS, Palermo NJ, Castaneda-Sceppa C, Rasmussen HM, Dallal GE Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women Journal of Clinical Endocrinology & Metabolism. 2009;J Clin Endocrinol Metab. 2009 Jan;94(1):96-102.PubMedUsed to support: Randomized double-blind trial in 171 men and women aged 50 and older (162 analyzed) assigned to placebo, potassium bicarbonate, sodium bicarbonate or potassium chloride at 67.5 mmol/day for 3 months, all with calcium and vitamin D. Participants receiving a bicarbonate salt had significant reductions in 24-hour urinary N-telopeptide and calcium excretion compared with those receiving no bicarbonate, while potassium supplementation on its own affected neither. Outcomes were urinary markers only.
  3. Macdonald HM, Black AJ, Aucott L, Duthie G, Duthie S, Sandison R, Hardcastle AC, Lanham New SA, Fraser WD, Reid DM Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial The American Journal of Clinical Nutrition. 2008;Am J Clin Nutr. 2008 Aug;88(2):465-74.PubMedUsed to support: Two-year randomized placebo-controlled trial in 276 postmenopausal women aged 55 to 65 testing high-dose (55.5 mEq/d) and low-dose (18.5 mEq/d) potassium citrate. Bone-turnover markers did not differ between groups, and spine bone mineral density loss in the placebo group (1.8%) did not differ from the treatment groups (2.1%). The authors concluded that potassium citrate supplementation does not reduce bone turnover or increase bone mineral density. This trial used potassium citrate, a different alkaline potassium salt from potassium bicarbonate.
  4. He FJ, Marciniak M, Carney C, Markandu ND, Anand V, Fraser WD, Dalton RN, Kaski JC, MacGregor GA Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives Hypertension. 2010;Hypertension. 2010 Mar;55(3):681-8.PubMedUsed to support: Twelve-week randomized, double-blind, placebo-controlled crossover trial in 42 adults with untreated mildly raised blood pressure. Potassium bicarbonate significantly reduced 24-hour urinary calcium, the calcium-to-creatinine ratio and plasma C-terminal telopeptide of type 1 collagen. Office blood pressure did not differ across the three treatment periods, and only potassium chloride slightly lowered 24-hour and daytime systolic pressure. Both potassium salts improved flow-mediated dilatation and arterial compliance.
  5. Jehle S, Hulter HN, Krapf R Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial The Journal of Clinical Endocrinology and Metabolism. 2013;J Clin Endocrinol Metab. 2013 Jan;98(1):207-17.PubMedUsed to support: Two-year randomized double-blind placebo-controlled trial in 201 healthy adults over 65, all receiving calcium and vitamin D. Potassium citrate at 60 mEq/day increased lumbar spine areal bone mineral density by 1.7% net of placebo at 24 months and improved trabecular density and microarchitecture at the radius and tibia. Fracture risk was estimated by the FRAX prediction score rather than by counting fractures, and the salt tested was potassium citrate rather than potassium bicarbonate.
  6. Lambert H, Frassetto L, Moore JB, Torgerson D, Gannon R, Burckhardt P, Lanham-New S The effect of supplementation with alkaline potassium salts on bone metabolism: a meta-analysis Osteoporosis International. 2015;Osteoporos Int. 2015 Apr;26(4):1311-8.PubMedUsed to support: Meta-analysis of 14 studies of potassium bicarbonate and potassium citrate: both salts significantly lowered urinary calcium, net acid excretion and the bone-resorption marker NTX, and both lowered calcium excretion more than potassium chloride did. There was no effect on bone-formation markers or on bone mineral density.
  7. Ceglia L, Konieczynski E, Danico E, Trinquart L, Koethe B, Xiang Q, Fielding RA, Evans WJ, Shankaran M, Dawson-Hughes B Independent effects of whey protein and alkali supplementation on muscle health in healthy older adults: factorial randomized controlled trial The American Journal of Clinical Nutrition. 2026;Am J Clin Nutr. 2026 May;123(5):101257.PubMedUsed to support: Randomized 2x2 factorial placebo-controlled trial in 128 healthy adults aged 65 and over (mean age 74). Potassium bicarbonate at 81 mmol/day for 24 weeks did not change double leg press muscle power, physical performance, DXA lean mass or D3-creatine muscle mass compared with placebo, although serum IGF-1 was 7.2 ng/mL higher.